<!DOCTYPE html>
<html>
  <head>
    <meta charset="utf-8">
    <title></title>
    <link rel="stylesheet" href="../../css/uswds.min.css">
    <link rel="stylesheet" href="../../css/style.css">
  </head>
  <body>

    <header>
        <h2 class="title">
            <a href="../../index.html">Code of Federal Regulations (alpha)</a>
        </h2>
    </header>

    <div class="usa-grid">
      <div class="usa-width-one-whole">
          <h3>
                                <a href="../../index.html">CFR</a><span>&nbsp/&nbsp</span>
                                <a href="../titles/title19.html">
                                    Title 19
                                </a><span>&nbsp/&nbsp</span>
                                <a href="../parts/19CFR12.html">Part 12
                                </a><span>&nbsp/&nbsp<span>
                                Sec. 12.23  Detention; examination; disposition.
                            </h3>
                            <p class="depth1"><em>(a)</em> Port directors shall detain all importations of unlicensed  viruses, therapeutic serums, toxins, antitoxins, and analogous products,  and arsphenamines or its derivatives (or any other trivalent organic  arsenic compound) for the treatment or cure of diseases or injuries of  man pending examination by the Director, Bureau of Biologics, unless  satisfied from evidence furnished at the time of entry that the products  are intended solely for purposes of controlled investigation and not for  sale, barter, or exchange, as evidenced by a copy of a filed ``Notice of  Claimed Investigational Exemption for a New Drug,'' pursuant to Sec.  312.1 of the Food, Drug, and Cosmetic Act Regulations (21 CFR 312.1), or  are being imported under the short supply provisions of Sec. 601.22 of  the Public Health Service Regulations (42 CFR 601.22).</p><p class="depth1"><em>(b)</em> If the shipment is imported for sale, barter, or exchange and is  found by the Director, Division of Biologics Standards, to be  admissible, the port director shall release it upon receipt of a report  from him that the shipment is admissible.</p><p class="depth1"><em>(c)</em> If the Director, Division of Biologics Standards, reports that  the shipment was found upon examination not to conform to the law and  the regulations, the port director shall not release the shipment but  shall permit the exportation or destruction thereof under Customs  supervision at the option of the importer.</p><p class="depth1"><em>(d)</em> Shipments of such products for use in the treatment of man but  made from or with material of animal origin other than human, shall,  unless accompanied by a Department of Agriculture, Veterinary Services,  Animal and Plant Health Inspection Service (APHIS) permit, be detained  until proof is presented to the port director that their   importation is not prohibited under 9 CFR part 94 or part 122.  [T.D. 69-201, 34 FR 14328, Sept. 12, 1969, as amended by T.D. 82-145, 47  FR 35476, Aug. 16, 1982]</p><p class="depth2">Domestic Animals, Animal Products, and Animal Feeding Materials</p>
      </div>
    </div>

    <footer class="usa-footer usa-footer-slim" role="contentinfo">
    <div class="usa-grid usa-footer-return-to-top">
      <a href="#">Return to top</a>
    </div>
    <div class="usa-footer-primary-section">
      <div class="usa-grid-full">
        <h5>Built with ‚ù§ by <a href="https://18f.gsa.gov/">18F</a>.
          Code available <a href="https://github.com/18F/allregs">on Github.
        </a></h5>
        <h5>All regulations are from the 2015 Annual Edition.
          This is a technical demonstration not intended for serious use.</h5>
      </div>
    </div>
  </footer>
  </body>
</html>
